India to Venezuela: Empagliflozin Export Trade Route

The India to Venezuela Empagliflozin corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $233.6K USD. The route is dominated by S.D.PHARMACEUTICALS, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $10.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with empagliflozin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 30.0%, placing it at rank #19 among India's top empagliflozin export destinations globally.

On the import side, key buyers of Indian empagliflozin in Venezuela include TO THE ORDER OF, TO THE ORDER OF , Integralmedic, C.A. and 5 others. TO THE ORDER OF is the single largest importer with 11 shipments valued at $125.7K USD.

India's empagliflozin exports to Venezuela are driven primarily by a handful of large-scale manufacturers. S.D.PHARMACEUTICALS with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Venezuela benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — S.D.PHARMACEUTICALS, ZENITH HEALTHCARE LIMITED, RONALD PHARMACEUTICALS PRIVATE LIMITED — together account for 63% of total trade value on this route. The average shipment value of $10.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as h.l.medicine - gluvex -10mg (empagliflozin tablets 10 mg.) and empagliflozin tablets 25mg batch no. gt753, mfg: 05/2023, exp: 04/2026, against advance license no - 3011004055 date -, suggesting that buyers in Venezuela tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 11 shipments worth $125.7K USD — representing 54% of all empagliflozin imports from India on this route. A total of 8 buyers are active on this corridor.